Ep. 75: Drug Supply Chain & Privacy – Ben Taylor (CEO LedgerDomain)

Health Unchained

Ep. 75: Drug Supply Chain & Privacy – Ben Taylor (CEO LedgerDomain)

Ben Taylor is the CEO of LedgerDomain, founded in…
November 7, 2020

Ep. 75: Drug Supply Chain & Privacy – Ben Taylor (CEO LedgerDomain)

Ben Taylor is the CEO of LedgerDomain, founded in 2016 to bring blockchain solutions to enterprise ecosystems. Ben spent a quarter of a century incubating and investing in early-stage technology companies. In partnership with the Clinical Supply Blockchain Working Group, LedgerDomain developed the world’s first iOS blockchain app for the clinical supply chain. He’s also founder of Sophrosyne Capital which has been running for over 15 years.

LedgerDomain Website:

Ben recently spoke at the IEEE Virtual Series on Blockchain and AI. Ben’s presentation on Blockchain and Vaccine Supply Assurance:


Introduction to Ben’s background
•How did you first hear about blockchain technology?
•What is the vision for LedgerDomain? Why did you start it?
•What drove you to the healthcare industry?
•What’s your take on the impact of the recent FDA delay who said they do not intend to take action against wholesale distributors who do not, prior to November 27, 2023, verify the product identifier prior to further distributing returned product as required under section 582(c)(4)(D) of the [Federal Food, Drug, and Cosmetic Act] FD&C Act? How may this impact competition who can enter the space?
•What is the last mile of the pharma supply chain?
•What is the impact of COVID-19 on pharma supply chain and on LedgerDomain?
•COVID-19 Vaccine supply chain expectations
•Can you describe LedgerDomain’s services/products/platforms and their technology stacks?
oOpen Source, Hyperledger Fabric, AWS servers, Linux Foundation
oKitchain (push system) and BRUINchain (pull system)
•Distributed Identity
•What is LedgerDomain’s business model?
•What are the biggest barriers to blockchain adoption in healthcare?
•Privacy/Security enclaves on Mobile
•How does running a hedge fund (Sophrosyne Capital) inform the way you approach the blockchain world?
•Inventory management accuracy solutions
•How would you describe the company culture at LedgerDomain?
•Outlook for 2021 and beyond
•Favorite DLT projects doing important work not our own? Really like Atomyze for precious metals. Spam deterrence in India.
•What’s your take on Bitcoin?
•Most influential book you’ve read – Creative Industries: Contracts Between Art and Commerce by Richard E. Caves
•Final Takeaways

Health Unchained News Corner
With the passing of California’s ballot measure Proposition 24 or the California Privacy Rights Act (CPRA), the state has become the country’s leader in data privacy legislation. CPRA adds to California’s existing law, the California Consumer Privacy Act (CCPA) which gives Californians the power to know what data businesses collect about them and prevent businesses from selling that data to anyone else. The new CPRA law would close some legal loopholes in the CCPA.
Proposition 24’s provisions give Californians the ability to tell businesses not to use certain categories of sensitive information, including race, health, religion, location, sexual orientation, and biometrics. It makes more explicit that “do not sell” includes data shared between companies. And it triples fines for violations if the affected consumer is younger than 16 years old.
It provides funding for a Privacy Protection Agency that would be charged with enforcing privacy laws.
Overall, the passage of the CPRA will drive more interest in privacy preserving technologies that decentralized ledger technology can potentially offer our society.

Health Unchained Links

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp